{"id":"https://openalex.org/W4399129397","doi":"https://doi.org/10.58837/chula.the.2021.1188","title":"The effect of N-trans-p-coumaroyl tyramine on indomethacin-/diclofenac-mediated-cytotoxicity in breast cancer cells.","display_name":"The effect of N-trans-p-coumaroyl tyramine on indomethacin-/diclofenac-mediated-cytotoxicity in breast cancer cells.","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W4399129397","doi":"https://doi.org/10.58837/chula.the.2021.1188"},"language":"en","primary_location":{"id":"doi:10.58837/chula.the.2021.1188","doi":"https://doi.org/10.58837/chula.the.2021.1188","is_oa":false,"landing_page_url":"https://doi.org/10.58837/chula.the.2021.1188","pdf_url":null,"source":{"id":"https://openalex.org/S7407060144","display_name":"Chula Digiverse","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chulalongkorn University","raw_type":"dissertation"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083676587","display_name":"Angkana Wongsakul","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Angkana Wongsakul","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Suree Jianmongkol","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suree Jianmongkol","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5083676587"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.36039999127388,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.36039999127388,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.19179999828338623,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11332","display_name":"Genomics, phytochemicals, and oxidative stress","score":0.07880000025033951,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/indomethacin","display_name":"indomethacin","score":0.9610000252723694},{"id":"https://openalex.org/keywords/diclofenac","display_name":"diclofenac","score":1.0},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.6949999928474426},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8519999980926514},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.9700000286102295},{"id":"https://openalex.org/keywords/mitoxantrone-resistance","display_name":"mitoxantrone resistance","score":0.8629999756813049},{"id":"https://openalex.org/keywords/endoplasmic-reticulum-stress","display_name":"endoplasmic reticulum stress","score":0.859000027179718},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7070000171661377},{"id":"https://openalex.org/keywords/bax-bcl-2-ratio","display_name":"Bax/Bcl-2 ratio","score":0.8370000123977661},{"id":"https://openalex.org/keywords/nrf2-ho-1-signaling-pathway","display_name":"Nrf2/HO-1 pathway","score":0.8199999928474426},{"id":"https://openalex.org/keywords/coumaric-acid-derivatives","display_name":"coumaric acid derivatives","score":0.902999997138977},{"id":"https://openalex.org/keywords/drug-combination-cytotoxicity","display_name":"drug combination cytotoxicity","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.7967168092727661},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6323513388633728},{"id":"https://openalex.org/C109541995","wikidata":"https://www.wikidata.org/wiki/Q1881253","display_name":"MCF-7","level":5,"score":0.6024661660194397},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.5855807662010193},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5830888152122498},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5648260116577148},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.49072396755218506},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.4548928141593933},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.4475539028644562},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4384193420410156},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4290663003921509},{"id":"https://openalex.org/C158617107","wikidata":"https://www.wikidata.org/wiki/Q79927","display_name":"Endoplasmic reticulum","level":2,"score":0.42778652906417847},{"id":"https://openalex.org/C139447449","wikidata":"https://www.wikidata.org/wiki/Q14633900","display_name":"Unfolded protein response","level":3,"score":0.4225071966648102},{"id":"https://openalex.org/C2780133158","wikidata":"https://www.wikidata.org/wiki/Q414501","display_name":"Piperine","level":2,"score":0.4123242497444153},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3292466104030609},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2941431403160095},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27661705017089844},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.2395378053188324},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2352866232395172},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2253926396369934},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.21687749028205872},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17273744940757751},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12681123614311218},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C2994423619","wikidata":"https://www.wikidata.org/wiki/Q9103","display_name":"Human breast","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.58837/chula.the.2021.1188","doi":"https://doi.org/10.58837/chula.the.2021.1188","is_oa":false,"landing_page_url":"https://doi.org/10.58837/chula.the.2021.1188","pdf_url":null,"source":{"id":"https://openalex.org/S7407060144","display_name":"Chula Digiverse","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chulalongkorn University","raw_type":"dissertation"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220877179","https://openalex.org/W2159403654","https://openalex.org/W4321796183","https://openalex.org/W2149987837","https://openalex.org/W2161889546","https://openalex.org/W2233556253","https://openalex.org/W7095544885","https://openalex.org/W1987264263","https://openalex.org/W2082173056","https://openalex.org/W4412935975"],"abstract_inverted_index":{"Indomethacin":[0],"(INDO)":[1],"and":[2,47,65,74,100,169,188],"diclofenac":[3],"(DIC)":[4],"are":[5],"non-steroidal":[6],"anti-inflammatory":[7],"(NSAIDs)":[8],"have":[9],"been":[10],"reported":[11],"their":[12,89,135],"anticancer":[13],"potential.":[14],"Their":[15],"cytotoxicity":[16,68,208],"could":[17,203],"be":[18],"increased":[19,189],"when":[20],"combining":[21],"with":[22,81,149,163],"certain":[23],"natural":[24],"compounds":[25],"such":[26],"as":[27],"piperine":[28],"in":[29,44,51,69,98,161,171,181,217],"Piper":[30],"plants.":[31],"N-trans-p-coumaroyltyramine":[32],"(TCT)":[33],"(a":[34],"coumaric":[35],"acid":[36],"derivative)":[37],"was":[38,141],"also":[39,179],"found":[40],"at":[41,88],"significant":[42],"amount":[43],"these":[45],"plants":[46],"other":[48],"commonly":[49],"used":[50],"traditional":[52],"medicine.":[53],"This":[54],"study":[55],"determined":[56],"the":[57,75,121,139,164,177,192],"potentiative":[58],"effect":[59,133],"of":[60,79,116,143,147,166,184,191,209],"TCT":[61,80,129,148,202],"on":[62,134],"NSAIDs":[63,83,151],"(INDO":[64],"DIC)":[66],"induced":[67],"MCF-7":[70,99,123,173,210,218],"breast":[71,219],"cancer":[72,220],"cells,":[73],"underlying":[76],"mechanisms.":[77],"Combination":[78],"either":[82,150],"or":[84,152,206],"various":[85],"ER":[86,153,214],"stressors":[87,154],"non-cytotoxic":[90],"concentrations":[91],"were":[92],"able":[93],"to":[94],"reduce":[95],"cell":[96,174],"viability":[97],"mitoxantrone-resistant":[101],"MCF-7/MX":[102,111],"cells":[103,112,211],"after":[104],"48":[105],"h":[106],"treatment.":[107],"In":[108,200],"this":[109],"study,":[110],"expressed":[113],"higher":[114],"activities":[115],"efflux":[117],"transporter":[118],"(BCRP)":[119],"than":[120],"parental":[122],"cells.":[124,221],"The":[125],"results":[126],"showed":[127],"that":[128,138],"had":[130],"no":[131],"inhibitory":[132],"activities,":[136],"suggesting":[137],"potentiation":[140],"independent":[142],"transporters.":[144],"Evidently,":[145],"combination":[146,178],"significantly":[155],"reduced":[156],"mitochondria":[157],"membrane":[158],"potential":[159],"(MMP)":[160],"concurrent":[162],"rising":[165],"Bax/BcL-2":[167],"ratio":[168],"apoptosis":[170,216],"both":[172],"types.":[175],"Furthermore,":[176],"resulted":[180],"decreased":[182],"expression":[183],"survival":[185],"proteins":[186],"p-Nrf-2/HO-1,":[187],"activation":[190],"endoplasmic":[193],"reticulum":[194],"(ER)":[195],"stress":[196],"signaling":[197],"PERK/eIF-2a/ATF-4/CHOP":[198],"pathways.":[199],"conclusion,":[201],"increase":[204],"INDO":[205],"DIC":[207],"by":[212],"promoting":[213],"stress-dependent":[215]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2024-05-30T00:00:00"}